528108 | PI 3-Kγ Inhibitor II - CAS 648449-76-7 - Calbiochem

528108
Preis nicht abrufbar
Minimum Quantity needs to be mulitiple of
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
Bitte erfragen
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Remaining : Will advise
      Bitte erfragen
      Preis & Verfügbarkeit
         VergleichenClick To Print This Page

      Overview

      Replacement Information

      Key Spec Table

      Empirical Formula CAS #
      C₁₁H₅F₂NO₄S 648449-76-7

      Preis & Verfügbarkeit

      BestellnummerVerfügbarkeit Verpackung St./Pkg. Preis Menge
      US1528108-5MG
      Verfügbarkeit wird abgerufen...
      Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
      Produkt wurde eingestellt
      Begrenzter Lagerbestand
      Bestätigung der Verfügbarkeit erforderlich
        Remaining : Will advise
          Bitte erfragen

          5 mg
          Preis wird abgerufen...
          Preis nicht abrufbar
          Minimum Quantity needs to be mulitiple of
          Bei Bestätigung Weitere Informationen
          Sie haben () gespart
           
          Bitte erfragen
          Description
          Overview A cell-permeable thiazolidinedione compound that acts as a potent and ATP-competitive inhibitor of PI 3-Kγ (Ki = 180 nM; IC50 = 250 nM). Exhibits great selectivity over PI 3-Kα (IC50 = 4.5 µM), PI 3-Kβ and δ (IC50 > 20 µM), and shows little effect towards a large panel of receptors, unrelated enzymes, ion channels, and 38 commonly studied kinases. Shown to block MCP-1-mediated monocyte chemotaxis in vitro and exhibit better in vivo efficacy than LY294002 (Cat. No. 440202 and 440204) in blocking RANTES- or thioglycollate-induced peritoneal neutrophil recruitment by oral administration in a murine peritonitis model.
          Catalogue Number 528108
          Brand Family Calbiochem®
          Synonyms 5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione, PI 3-K Inhibitor II
          References
          References Bilancio, A., et al. 2006. Blood 107, 642.
          Camps, M., et al. 2005. Nat. Med. 11, 936.
          Product Information
          CAS number 648449-76-7
          ATP Competitive Y
          Form Off-white solid
          Hill Formula C₁₁H₅F₂NO₄S
          Chemical formula C₁₁H₅F₂NO₄S
          Molar Mass 285.2
          Reversible N
          Structure formula Image
          Applications
          Biological Information
          Primary Target PI 3-Kγ
          Primary Target IC50 250 nM against PI 3-Kγ
          Primary Target Ki 180 nM
          Purity ≥98% by HPLC
          Physicochemical Information
          Cell permeable Y
          Solubility DMSO or EtOH
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Irritant
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDB

          Sprachen
          Argentina Australia Belgie
          Belgien Belgique Brasil
          Canadian English Canadian French Ceská Rep
          Chile China Colombia
          Cyprus Danmark Deutschland
          Eesti Ellas English
          España France Hrvatska 
          Iceland India Indonesia
          Italia Korea Latvija
          Lietuva Magyarország Malta
          México Nederland  Norge
          Peru Polska Portugal
          Schweiz Slovenija Slovensko
          Srpski Standard EU English Suisse
          Suomi Sverige Svizzera
          Taiwan Thailand Türkiye
          US English United Kingdom Éire
          Österreich България Россия

          Analysenzertifikate

          TitelChargennummer
          528108

          Literatur

          Übersicht
          Bilancio, A., et al. 2006. Blood 107, 642.
          Camps, M., et al. 2005. Nat. Med. 11, 936.
          Datenblatt

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision 27-March-2008 RFH
          Synonyms 5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione, PI 3-K Inhibitor II
          Description A cell-permeable thiazolidinedione compound that acts as a potent and ATP-competitive inhibitor of PI 3-Kγ (Ki = 180 nM; IC50 = 250 nM). Exhibits great selectivity over PI 3-Kα (IC50 = 4.5 µM), PI 3-Kβ and δ (IC50 > 20 µM), and shows little effect towards a large panel of receptors, unrelated enzymes, ion channels, and 38 commonly studied kinases. Shown to block MCP-1-mediated monocyte chemotaxis in vitro and exhibit better in vivo efficacy than LY294002 (Cat. No. 440202 and 440204) in blocking RANTES- or thioglycollate-induced peritoneal neutrophil recruitment by oral administration in a murine peritonitis model.
          Form Off-white solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number 648449-76-7
          Molar mass 285.2
          Chemical formula C₁₁H₅F₂NO₄S
          Structure formula
          Purity ≥98% by HPLC
          Solubility DMSO (10 mg/ml) or Ethanol (5 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze No
          Special Instructions Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Irritant
          References Bilancio, A., et al. 2006. Blood 107, 642.
          Camps, M., et al. 2005. Nat. Med. 11, 936.